Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2022 Jun 7;32(1):138–139. doi: 10.1684/ejd.2022.4236

Advocacy for a shared physician/patient approach for the management of acne, rosacea, seborrheic dermatitis and photodamage

Brigitte Dréno 1,✉, Richard L Gallo 2, Enzo Berardesca 3, Christopher E M Griffiths 4
PMCID: PMC9170546  PMID: 35653084

The content is available as a PDF (213.8 KB).

Acknowledgments and disclosures

the authors acknowledge the organisational and financial support of Marlène Chavagnac, NAOS, France and Karl Patrick Göritz, SMWS, France for the help in writing this article.

Financial support

this work was organised and funded by NAOS, Lyon, France.

Footnotes

Conflicts of interest

the authors received honoraria for participating in this work.

References

  • 1.Tian Q, Price ND, Hood L. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med. 2012;271:111–21. doi: 10.1111/j.1365-2796.2011.02498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.van de Kerkhof PC. Psoriasis in the perspective of predictive, preventive participatory and personalized medicine. J Dermatolog Treat. 2018;29:107–8. doi: 10.1080/09546634.2018.1437739. [DOI] [PubMed] [Google Scholar]
  • 3.Dreno B, Amici JM, Demessant-Flavigny AL, et al. The impact of acne, atopic dermatitis, skin toxicities and scars on quality of life and the importance of a holistic treatment approach. Clin Cosmet Investig Dermatol. 2021;14:623–32. doi: 10.2147/CCID.S315846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Passeron T, Krutmann J, Andersen ML, Katta R, Zouboulis CC. Clinical and biological impact of the exposome on the skin. J Eur Acad Dermatol Venereol. 2020;34:4–25. doi: 10.1111/jdv.16614. [DOI] [PubMed] [Google Scholar]
  • 5.Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A. The influence of exposome on acne. J Eur Acad Dermatol Venereol. 2018;32:812–9. doi: 10.1111/jdv.14820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011;8:184–7. doi: 10.1038/nrclinonc.2010.227. [DOI] [PubMed] [Google Scholar]
  • 7.Connolly D, Vu HL, Mariwalla K, Saedi N. Acne scarring-pathogenesis, evaluation, and treatment options. J Clin Aesthet Dermatol. 2017;10:12–23. [PMC free article] [PubMed] [Google Scholar]
  • 8.Oge LK, Muncie HL, Phillips-Savoy AR. Rosacea: diagnosis and treatment. Am Fam Physician. 2015;92:187–96. [PubMed] [Google Scholar]
  • 9.Dreno B, Bordet C, Seite S, Taieb C. Acne relapses: impact on quality of life and productivity. J Eur Acad Dermatol Venereol. 2019;33:937–43. doi: 10.1111/jdv.15419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chernyshov PV, Lallas A, Tomas-Aragones L, et al. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on quality of life and patient oriented outcomes, melanoma and non-melanoma skin cancer. J Eur Acad Dermatol Venereol. 2019;33:816–27. doi: 10.1111/jdv.15487. [DOI] [PubMed] [Google Scholar]

Articles from European Journal of Dermatology are provided here courtesy of Nature Publishing Group

RESOURCES